#Cell Freezing Media market forecast

[chetanagblog]

Cell Freezing Media Market is expected to reach USD 983.41 Mn. at a CAGR of 4.3% during the forecast period 2030.

[organicmarketresearch1]

Global Biopreservation Market Size, Share, Trends, Growth & Industry 2032

Global Biopreservation market size was USD 3.11 billion in 2023 and the market is projected to touch USD 23.73 billion by 2032, at a CAGR of 25.33 % during the forecast period. Biopreservation refers to keeping alive of biological samples, cells, tissues and organs in a state of stability through cooling or freezing them so as to prolong their shelf life and retain their quality for use in future. It is very important to different sectors such as healthcare, pharmaceuticals and R&D where there is need for such materials to be kept for conducting tests or treatments or even transplanting an organ. Biopreservation market is made up of various types of products and services aimed at making this process easier including specialized storage devices, chemicals used for preventing spoilage known as cryoprotectants together with solutions which keep them alive known as preservation media among others which fall under sample management aspects or transport in different ways or even departments in specific institutions.

Recent years have witnessed a substantial increase in the global biopreservation market owing to a number of different factors. Demand for specific drugs and treatments coupled with regenerative surgeries that necessitate personal data storage on life supporting materials is one primary force creating an impact on this trend. Moreover, there is growing rates of chronic illnesses development along with rising counts of organ transplant procedures which has led to the demand for efficient biopreservation methods. However, obstacles like regulations, ethics, and expensive storage facilities seem to be preventing the market from growing. The global biopreservation market is projected to grow in the future as research into improving biopreservation techniques continues and their application area broadens, this will provide an opportunity for those concerned in healthcare industries.

Global Biopreservation report scope and segmentation.

Report Attribute

Details

Base Year

2023

Forecast Years

2024–2032

Estimated Market Value (2023)

USD 3.11 Billion

Projected Market Value (2032)

USD 23.73 Billion

Segments Covered

By Product, By Application Area, By End User, & By Region.

Forecast Units

Value (USD Million or Billion)

Quantitative Units

Revenue in USD million/billion and CAGR from 2024 to 2032.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, GCC Countries, and South Africa, among others.

Download Free Sample Report

Global Biopreservation dynamics

There are several key factors driving the biopreservation market, one of which is increase in the demand for personalized medicine and regenerative therapies. This results in the necessity to preserve individualized biologic samples. This means that as more precise treatments are being designed for specific patients, there is an urgent need for proven biopreservation techniques to keep these samples. Furthermore, numerous other factors account for the expanding market for biopreservation solutions which is promoted by the increasing number of patients with chronic conditions as well as growing organ transplantations globally. Many people are now in need of long-term treatment such as regular medical care, then this implies a rise in the use of conserved living things for scientific study, detection, and treatment.

Similarly, biotechnology and cell therapy research can change the biopreservation market. Furthermore, given that stem cell therapy and gene editing present new opportunities, protecting biological samples is given much attention to aid in continuous research and development efforts. The world is driven by the need for new biopreservation technologies and services designed to preserve various biological materials alive and functioning. Moreover, these collaborations among academia, industry and government have played a significant role in enhancing knowledge sharing, resource availability, funds provision among others in order to support research on biopreservation.

Get Complete Report: https://organicmarketresearch.com/global-biopreservation-market

Global Biopreservation drivers

Rise in Personalized Medicine

Biopreservation market gains a lot due to the strong spike in favour of personalized medicine a medical trend that involves tailoring treatments to the individual patient’s genetic composition. This form of medicine calls for storing bodily fluids taken from a patient for future use during diagnosis or research. The rise in awareness about genetic factors determining disease susceptibility and response to treatments leads to a growing need for biopreservation solutions to hold these examples. This phenomenon does not only encourage the utilization of biopreservation techniques in health care, but also brings together biobanks with research organizations and pharmaceutical firms in order to create targeted treatments.

Advancements in Biotechnology

The demand for innovative biopreservation solutions is driven by continuous advancements in biotechnology especially in cell therapy, regenerative medicine, and tissue engineering areas. Maintaining the viability and functionality of live cells and tissues used for new therapeutic modalities being explored in the research community requires specific approaches in their preservation. Induced pluripotent stem cells (iPSCs) have revolutionized research into effective therapies. They need precise cryopreservation procedures, however, for the cell to remain intact when stored or defrosted. In view of the above, biopreservation industry stakeholders should anticipate an upward trajectory as biology burgeons and advanced therapeutics demand top of the range conservation methods.

Restraints:

Regulatory Constraints

Regulatory compliance is indeed a challenge that the market of biopreservation is facing more so regarding the storage and transportation of biological samples. As a result of these regulations and guidelines put in place, preserved specimens have to be handled, labelled and documented in accordance with stringent measures which in turn make operations in biopreservation expensive and complex. Observing international standards such as Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) is key but can pose a challenge to smaller players or players operating in multiple jurisdictions.

High Cost of Specialized Equipment

The expensive characteristic of specified biopreservation equipment like ultra-low temperature freezers, automated storage systems and cryopreservation tanks have been an enormous obstacle to market expansion. It requires a lot of funds to establish and keep running biobanks or biorepositories that have latest facilities for preservation purposes. Additionally, the present operational costs like energy consumption and maintenance increases the cost hence limiting access to advanced solutions for biopreservation especially in low-resource contexts.

Opportunities:

Expansion of Biobanking Initiatives

The increasing focus on personalized medicine and biomolecular exploration will provide opportunities for expanding global biobanking endeavours. Biobanks are essential in scientific studies, particularly in sample preservation which boosts the need for bio-preservation solutions. By creating complete biobanking networks, it will allow biopreservation providers to offer their services and technologies which have been facilitated by collaborative efforts among academic institutions, healthcare organizations and government agencies.

Segment Overview

By product, the biopreservation market is segmented into Equipment, and Biopreservation Media. Equipment includes a range of devices used for the storage and preservation of biological samples, such as ultra-low temperature freezers, liquid nitrogen tanks, and automated storage systems. These products create environments that are carefully controlled which help maintain the condition of cells, tissues, and organs for extended periods. Also, biopreservation media refers to solutions or mixtures created specifically for safeguarding biological matter from various agents while still allowing storage or shipment. Usually within them are found anti-freezes as well as anti-oxidants together with other preservatives used in order to reduce injury imposed by such process as low temperature maintenance on living cells.

By application, the biopreservation market is segmented into drug discovery, biobanking, regenerative medicine, and other application areas. In drug discovery, biopreservation plays a crucial role in preserving cell lines, tissues, and biological samples used in screening assays, pharmacokinetic studies, and toxicity testing. Biobanking includes the collection, storage and distribution of biological specimens for research, clinical trials or diagnostic objectives, thus leading to an overwhelming demand for dependable biopreservation solutions which can preserve the integrity of samples. In regenerative medicine the conservation of stem cells, tissues and organs is a prerequisite for the production of new therapies to replace damaged tissues in patients. Biopreservation, besides, is also utilized in agriculture, veterinary medicine and environmental research where there is a demand for keeping samples for a long duration period to aid in scientific study as well as other works.

Global Biopreservation Overview by Region

With its well-established healthcare facilities, extensive research and development projects, as well as huge investments into biotechnology and pharmaceutical industries, North America is the leading market in the world. Biobanks, academic institutions and industry counterparts in collaboration have led to cutting edge innovations in biopreservation technologies and service delivery in this area. Initiatives promoting personalized medicine, regenerative therapies and biobanking networks as well as stringent regulatory standards has made Europe to follow closely in order to ensure the quality and safety of biopreserved samples which in turn fosters trust among stakeholders. The Asia Pacific region can undergo a swift expansion, arising from an upsurge of healthcare expenditure in this fast-growing industry, development of biopharmaceuticals and increased attention to preservation of living organisms in medicine. China, Japan, India, among others are putting up facilities for storing samples and studying preserved organisms in order to keep pace with rising needs of the developing countries. Furthermore, emerging economies in Latin America and the Middle East & Africa are witnessing rising investments in healthcare infrastructure and research capabilities, presenting untapped opportunities for market expansion.

Global Biopreservation market competitive landscape

The competitive landscape of the biopreservation market is identified by the presence of several key players, including Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, BioLife Solutions Inc., and Avantor Inc. These companies dominate the market through their extensive product portfolios, strong distribution networks, and strategic partnerships. They focus on innovation to develop advanced biopreservation solutions that meet the evolving needs of healthcare, pharmaceutical, and research industries. Additionally, mergers and acquisitions play a significant role in influencing the competitive factors, enabling companies to expand their market presence and enhance their capabilities in biopreservation technologies and services. In addition, the biopreservation domain is being penetrated by small companies and new market participants who offer narrow specialized products for certain uses or market segments. This increases competition and prompts larger corporations that wish to remain competitive to spend more on R&D activities.

Global Biopreservation Recent Developments

November 2023, BioLife Solutions announced a fundraising of USD 10.4 million through a private placement by Casdin Capital. The funds are intended to support ongoing operations related to biopreservation media and other offerings.

October 2022, Azenta, Inc. completed the acquisition of B Medical Systems S.á r.l and its subsidiaries. B Medical Systems is renowned for providing temperature-controlled storage and transportation solutions crucial for delivering life-saving treatments worldwide.

July 2022, the inauguration of Cellutions BioStorage took place in Chennai, India. As a research-to-launch Cryopreservation Bank, Cellutions BioStorage offers comprehensive biomaterial storage and logistics services. It caters to biopharmaceutical firms seeking to outsource supply chain management throughout a product’s life cycle. The newly opened facility spans 25,000 square feet and boasts state-of-the-art infrastructure.

Contact Us: Mob : +91 9319642100 Noida One Tower Sec 62 Noida 201301 Sales : sales@organicmarketresearch.com Website : https://www.organicmarketresearch.com

[maximizegn1]

The Maximize Market research report gives you a complete report of the Cell Freezing Media Market. The study focuses on developing Market trends and important growth factors to assist Market participants in identifying opportunities in the Cell Freezing Media Market. 

[report-1]

Serum Free Cell Freezing Medium Market Size, Type, segmentation, growth and forecast 2023-2030

Serum Free Cell Freezing Medium Market

The Serum Free Cell Freezing Medium Market is expected to grow from USD 2.60 Billion in 2022 to USD 4.30 Billion by 2030, at a CAGR of 6.70% during the forecast period.

Get the Sample Report:https://www.reportprime.com/enquiry/sample-report/11007

Serum Free Cell Freezing Medium Market Size

Serum Free Cell Freezing Medium is a type of solution used to preserve cells for future use by cryopreservation, without the need for serum. The market for Serum Free Cell Freezing Medium is segmented based on type, application, and region. The two main types include those with and without DMSO, while the application segment includes academic research institutions and pharmaceutical biotechnology companies. The market is further categorized regionally into North America, Asia Pacific, Middle East, Africa, Australia and Europe. The key players in the market include Thermo Fisher, Merck, Zenoaq, STEMCELL, GE Healthcare, BioLifeSolutions, Bio-Techne, Lonza, Biological Industries, Nippon Genetics, HiMedia, and PromoCell. The regulatory and legal factors specific to market conditions refer to the laws and standards that regulate the use and sale of Serum Free Cell Freezing Medium. This includes factors such as product labeling, storage requirements, and safety protocols. These factors can impact distribution and sales of the product, as well as research and development in the field.

Serum Free Cell Freezing Medium Market Key Player

Thermo Fisher

Merck

Zenoaq

STEMCELL

GE Healthcare

Buy Now & Get Exclusive Discount on this: https://www.reportprime.com/enquiry/request-discount/11007

Serum Free Cell Freezing Medium Market Segment

Analysis

The Serum Free Cell Freezing Medium market has a wide target market, including research institutions, biotechnology and pharmaceutical companies, clinical laboratories, and hospitals. The primary focus of this market is to preserve cells for future use and testing, allowing for the development of innovative treatments and therapies.

One of the major factors driving revenue growth in the Serum Free Cell Freezing Medium market is the increasing demand for efficient and cost-effective cell preservation techniques. With more emphasis being placed on personalized medicine and targeted therapies, there is a greater need for reliable cell storage and preservation options.

Another factor driving growth in this market is the advancements in cryopreservation technology, which has led to the development of more effective serum-free cell freezing mediums. These innovative solutions offer improved cell viability and functionality, which can increase the success rate of experiments and clinical trials.

The latest trends in the Serum Free Cell Freezing Medium market include the adoption of automation and robotics technology in the cell preservation process, which can improve precision and efficiency. Along with this, there is a rising trend towards the use of chemically defined serum-free cell freezing mediums, which can reduce the risk of contamination and improve cell stability.

However, the major challenge faced by the Serum Free Cell Freezing Medium market is the high cost associated with the development and production of these mediums. Additionally, maintaining the quality and consistency of the media can also be a challenge, which can impact the success of experiments and clinical trials.

Overall, the report's main findings suggest that the Serum Free Cell Freezing Medium market is expected to continue growing in the coming years, with increasing demand for efficient and cost-effective cell preservation techniques. To capitalize on this potential growth opportunity, companies in this market are recommended to focus on improving the quality and consistency of their products while also exploring innovative technologies to reduce production costs.

This report covers impact on COVID-19 and Russia-Ukraine wars in detail.

Purchase This Report: https://www.reportprime.com/checkout?id=11007&price=3590

Market Segmentation (by Application):

Academic Research Institutions

Pharmaceutical Biotechnology Company

Information is sourced from www.reportprime.com

[kritikapatil]

Cryogenic Freezing Systems Market Unidentified Segments – The Biggest Opportunity Of 2022

Advance Market Analytics released a new market study on Global Cryogenic Freezing Systems Market Research report which presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Cryogenic Freezing Systems Forecast till 2027*.

Cryogenic freezing is the most efficient IQF process available. Cryofreezing involves spraying or immersing the things in liquid nitrogen or carbon dioxide and freezing them practically immediately. The approach avoids macrocrystal growth, which is preferable because huge ice crystals tear cell membranes and induce fluid loss. The absence of macro crystals results in frozen and cooled food of the best quality, retaining its natural nutritional content, flavor, and shape. Cryogenic freezing is useful in areas where food safety and quality are critical, and it is commonly utilized by manufacturers who want to add value to their products. Special baked items, fish, meat, poultry, and dairy products are examples. Nonfood businesses, such as medicine and metal, are also affected.

Key Players included in the Research Coverage of Cryogenic Freezing Systems Market are

Arctiko (Denmark)

Thermo Fisher Scientific Inc. (United States)

Messer Group GmbH (Germany)

Russells Technical Products (United States)

Air Products and Chemicals, Inc. (United States)

Helmer Scientific (United States)

Emerson Electric Co. (United States)

Dohmeyer Construction Sp. z o.o. (Poland)

PHC Europe B.V. (Netherlands)

What's Trending in Market: Increasing Demand for Noise Reduction Technological System

Increasing Technological Advancement and Development

Challenges: Food Safety Is a Prime Concern for Any Food Process Industry

Opportunities: Growth of the Food Processing Industry Is Expected To Drive the Growth of Cryogenic Freezers

Growing Demand For Low Energy Consumption

Market Growth Drivers: Increasing Need for Proper Cryopreservation

Growing space and satellite missions bring opportunities for cryogenic freezing system

Increasing Demand for Cryogenic Freezers for Cryopreservation Application

The Global Cryogenic Freezing Systems Market segments and Market Data Break Down by Type (Spiral Freezer, Laboratory Freezer, Tunnel Freezer, Others), Application (Food Industry, Pharmaceutical, Metallurgical Industry, Others) To comprehend Global Cryogenic Freezing Systems market dynamics in the world mainly, the worldwide Cryogenic Freezing Systems market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas. • North America: United States, Canada, and Mexico. • South & Central America: Argentina, Chile, Colombia and Brazil. • Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa. • Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia. • Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia. Presented By

AMA Research & Media LLP

[mrfrblogresearch02]

Ultra-Low Temperature Freezers Market Report 2027: COVID-19 Implications And Growth

Market overview:

The ultra low-temperature freezer market Size has occupied a market value CAGR value of 5.67 percent during the forecast period. The market value has occupied a USD value of 989.44 million during the review period. The freezers are some of the medical professionals are very much capable of preserving the materials by freezing them. Some of the materials include enzymes, viruses, drugs, cell preparations, tissue pieces, and others. The temperature of the freezing takes palace at 40 degrees celsius where the lowest temperature is about 150 degrees celsius.

The freezers during the pandemic show a decrease in market demand and size. These ultra-low freezers can preserve the biological sample which contains COVID. The biomedical industry has helped in market development, especially during the pandemic. Increase in development and marketing of freezers that preserve biological material and also bring biological material. Has prompted the market to grow efficiently. Thes key players have has developed certain gaskets which help in resisting the frost.

Market segmentation

Based on type, the low-temperature freezer market has been classified into upright and chest. The upright segment has dominated the whole of the market covering a market value of USD 488.35 million. These units have been used up for manufacturing organized shelves for manufacturing biological materials. Based on application, the market is being segmented into drug products, blood and blood products, and biological samples. Blood unit has covered a market value of USD 259 million which accounts for high growing demand that will freeze up the blood products. Based on the end-user units, the market is being classified into hospitals and clinics, biobanks, research and academic settings, and others. the biobanks occupy a large market value because they kept other biological methods safe.

Regional analysis

The freezers market has been extended into the Americas, Asia Pacific, Europe Middle East, and Africa. The region of America has a covered market share with a large market value of USD 366.78 million with a CAGR value of 5.35 percent during the review period. The North American region has dominated the region due to high infrastructure and more overall spending. Some of the European regions comprise Germany, the UK, Italy, Spain, France, and some of the rest of Europe. the Asia Pacific region occupies a high CAGR value due to high overall ultrasound sales healthcare systems. Some of the Middle East and African region also occupies high CAGR value showing an influential rate.

Industry News

Some of the key players are VWR International LLC of the United States, Esco Micro Pte ltd of the US, Thermo Fischer Scientific of the US, Labcold of the United Kingdom, Eppendorf AG of Germany, BINDER Gmbh of Germany, Eppendorf AG of Germany, Helmer Scientific of the United States, Stirling Ultracold of Greece, Arctiko of the United Kingdom and PHC Corporation. PHC has launched an ultra-low temperature freezer along with an LCD display. It has developed and marketed the development of a new freezer along with a monitoring system. Helmer Scientific has attained a superior position by investing largely in both research and developmental activities.

List of companies”

VWR International, LLC(US)

Thermo Fisher Scientific (US)

Eppendorf AG (Germany)

Stirling Ultracold (Greece)

PHC Corporation (US)

Arctiko (UK)

Helmer Scientific (US)

BINDER GmbH (Germany)

Labcold (UK)

Esco Micro Pte Ltd (US)

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[adityarana1687-blog]

Primary Cell Culture Market To Surge Beyond $8.0 Billion By 2028

The global primary cell culture market size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. The market growth is owing to several factors such as advancement in genetic engineering, rising demand for regenerative medicines, and robust funding for cellular therapies development.

In addition, the growing focus on functional biology can be further attributed to the market growth. Several R&D investments for the development of novel solutions have increased the demand for culture medium. For instance, in April 2020, Sumitomo Chemical invested USD 30 million in Conagen a U.S.-based company. The investment was aimed at strengthening its alliance and developing high functional products as well as processes using synthetic biology.

Moreover, the ongoing COVID-19 pandemic has provided an opportunity for researchers to study and understand the new variants of the virus with the application of primary cell culture. The large pool of human cells from various genetic backgrounds and varied health conditions facilitated researchers to conduct experiments for thorough results. Various institutions have shown their support and interest in scientific research to match specialized cell culture media.

Request a free sample copy or view report summary: Primary Cell Culture Market Report

Primary Cell Culture Market Report Highlights

The reagents and supplements segment accounted for the largest revenue share in 2020 owing to their growing application for maintaining primary cell viability

The primary cells segment is expected to witness the fastest growth rate over the forecast period owing to the increasing research initiatives for cancer and rare diseases

The enzymatic degradation segment held the largest revenue share in 2020 due to the advantage of obtaining a high cellular yield through enzymatic disaggregation

The mechanical separation segment is expected to witness lucrative growth over the forecast period owing to its large adoption as it’s an inexpensive, quick, and easy method for disaggregation of cellular entities

The animal cells segment accounted for the largest revenue share in 2020 owing to rising applications for vaccine development

The human cells segment is expected to witness substantial growth over the forecast period as they are extensively used for preclinical and clinical analyses in cancer research

The vaccine production segment dominated the market in 2020 owing to the rising focus on the development of new vaccines targeting new infections such as COVID-19

The stem cell therapy segment is expected to witness the fastest CAGR over the forecast period owing to the growing number of studies for designing therapies for genetic disorders

North America held the largest revenue share in 2020. The growth of the market in this region is owing to intensive research for the development of new therapies

Companies operating in the market are launching new products for primary cell cultures. For instance, in January 2021, Lonza launched customizable and high-quality cryopreserved Leukopaks. It is a product derived from enriched leukapheresis, which contains high concentrations of peripheral blood mononuclear such as B and T cells, and monocytes

Primary Cell Culture Market Segmentation

Grand View Research has segmented the global primary cell culture market based on product, separation methods, cell type, application, and region:

Primary Cell Culture Product Outlook (Revenue, USD Million, 2017 - 2028)

Primary Cells

Reagents and Supplements

Media

Fat

Blood

Nerve

Bone

Endothelial

Skin

Muscle

Stem

Others

Attachment Solutions

Buffers and Salts

Freezing Media

Sera

Growth Factors and Cytokines

Other

Fat Cells Media

Blood Cells Media

Nerve Cells Media

Bone Cells Media

Endothelial Cells Media

Skin Cells Media

Muscle Cells Media

Stem Cells Media

Others

Primary Cell Culture Separation Methods Outlook (Revenue, USD Million, 2017 - 2028)

Explant Method

Enzymatic Degradation

Mechanical Separation

Others

Trypsin

Collagenase

Protease

Pronase

Dispase

Hyaluronidase

Neuraminidase

Elastase

DNase

Papain

Accutase

Others

Primary Cell Culture Cell Type Outlook (Revenue, USD Million, 2017 - 2028)

Animal

Human

Primary Cell Culture Application Outlook (Revenue, USD Million, 2017 - 2028)

Tissue Culture & Tissue Engineering

Vaccine Production

Gene Therapy and Regenerative Medicine

Toxicity Testing and Drug Screening

Cancer Research

Model System

Virology

Prenatal Diagnosis

Stem Cell Therapy

Others

Primary Cell Culture Regional Outlook (Revenue, USD Million, 2017 - 2028)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Germany

U.K.

China

Japan

Brazil

Mexico

South Africa

List of Key Players of Primary Cell Culture Market

Thermo Fisher Scientific, Inc.

Lonza

Merck

Corning Incorporated

Danaher

PromoCell GmbH

ATCC

FUJIFILM Irvine Scientific, Inc.

Mattek

Axol Bioscience Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[vicky8588]

Ophthalmology Amniotic Membrane Market, Size, Share, Outlook and Growth Opportunities 2021-2028

Market Overview

· The Global Ophthalmology Amniotic Membrane Market is expected to grow at a high CAGR during the forecasting period (2021-2028).

· Amniotic membrane is the innermost layer of the placenta which comprised of the combination of tissue and cells which acts as a wound healing for re-growth of soft tissue.  These amniotic membranes are used in the eye surgery for healing and replacing the damaged eye tissues as the biologically active cells are present in the epithelial and stromal layer of the Amniotic membrane release the growth factors and cytokines with anti-inflammatory, anti-immunogenic, and anti-fibrotic properties.

Download free sample: https://www.datamintelligence.com/download-sample/ophthalmology-amniotic-membrane-market

 Market Dynamics

·The market growth is driven by the rising demand for use of amniotic membrane as a biological bandage suitable for use on the eye surface due to its properties such as thin, lightweight, elastic, and transparent. These membranes are used for the treatment of chemical burns, cornea ulcers, and disorders leading to ulcerations during the surgical procedures involving the eye tissue excision.

·  The market is dominated by the presence of several ophthalmology amniotic membrane products. For instance, Dehydrated AmnioMatrix developed by Next Biosciences is a dry amniotic membrane that has had the epithelial layer of cells removed. It acts as a scaffold onto which new cells can grow once it has been placed on the wound. There is an increase in the research and development activities for the development of ophthalmology amniotic membranes over the forecasted period.

·  The market is witnessing the filing of the new patents related to the ophthalmology amniotic membrane. For instance, in May 2018, TissueTech Inc had been awarded patent 9,808,491 by the U.S. Patent Trademark Office. The patent covers the use of a gel composition comprising a morselized placental amniotic membrane and/or morselized umbilical cord. as a method for treating an ocular wound or repairing damaged ocular tissue.

· The increase in the number of accreditation from the different organizations and associations to several market players shall have a positive impact on the market. For instance,  in January 2020, LifeCell International had received the accreditation from the American Association of Tissue Banks (AATB) for its birth tissue products including the placenta, umbilical cord, amniotic fluid, and placental amniotic membrane. This accreditation would position LifeCell as the first & only company not only in India but also outside the US to receive this accreditation. This accreditation certifies the entire process of consent, birth tissue acquisition, processing, release, storage, and distribution.

Segmentation Analysis

·         Global ophthalmology amniotic membrane market is segmented based on type Cryopreserved Amniotic Membrane, and Lyophilization Amniotic Membrane. Cryopreserved amniotic membrane segment accounts for the highest market share due to the high usage of cryopreserved amniotic membranes in eye surgeries to heal or replace the eye tissue due to their ability to retains the histological and morphological properties of fresh tissue.

·Slow-rate freezing preservation techniques involving the slow freezing of Cryopreserved amniotic membrane at –80°C using DMEM/glycerol preservation media. This slow-rate freezing preservation technique is effective in retaining the extracellular matrix components, such as heavy-chain hyaluronic acids, growth factors, fibronectin, and collagen, all of which promote anti-inflammatory effects and healing.

· Lyophilization amniotic membrane segment is expected to witness the positive market growth in 2019. Lyophilization amniotic membrane has a higher rate of graft take,  longer shelf life, easier to store, and safer due to gamma irradiation in comparison to the Cryopreserved amniotic membrane.

·Further, the market is also classified based on end user into hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutes. Hospitals segment accounts for the highest market share as the hospitals are primary care settings facilitating easy treatment. A large number of patients with eye disorders visit hospitals. There is the easy availability of ophthalmology amniotic membranes in hospitals. It is further expected that this segment would maintain its dominant position over the forecasted period.

· Research and academic institutes segment is expected to have positive market growth owing to rising research and development activities for ophthalmology amniotic membranes. There is an increase in the investment by major companies and organizations for accelerating the development of ophthalmology amniotic membranes.

Geographical Share

·By region, the global ophthalmology amniotic membrane market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East and Africa. Among all of the regions, the North America region dominated the global ophthalmology amniotic membrane market due to the presence of a large number of companies developing the ophthalmology amniotic membrane. The presence of well-developed healthcare infrastructure with increased healthcare spending shall have a positive impact on the market.

·  According to the Committee for a Responsible Federal Budget, healthcare spending is highest in the United States in comparison to the other countries. Healthcare spending was USD 3.5 trillion in the United States in 2017.

·T he Asia-Pacific region is expected to have a significant market share due to the  increase in the investment related to the research and development activities for ophthalmology amniotic membranes. Several multinational companies are investing in developing countries especially India, China, and Japan. The market is witnessing the technological advancement for developing ophthalmology amniotic membranes.

· Growing awareness, rising disposable income, and growing purchasing power of the people shall stimulate the market growth over the forecasted period.

Competitive Landscape

·  The global ophthalmology amniotic membrane market is highly competitive with the presence of several domestic and international players. FzioMed, Inc., Amniox Medical, Inc., Human Regenerative Technologies, LLC, Amnio Technology, LLC, Derma Sciences, and MiMedx Group, Inc. are the leading market players with the significant market share. Companies are following new product launches, product diversification, market expansion strategies for increasing their market penetration

·  The market entry of new players intensifies the market competition. For instance, in July 2018, BioStem Life Sciences had entered the market with four placental-derived tissue products including the multiple indications including ophthalmology, orthopedic and advanced wound care markets. These four products are amniotic tissue allograft flowable matrix, a chorion-free amniotic tissue allograft membrane, an amniotic tissue allograft membrane with chorion layer, and an extracellular amniotic membrane allograft for ocular repair.

·  The companies are entering into the collaborations, mergers, strategic partnerships, purchasing agreements, and acquisitions to increase the demand for ophthalmology amniotic membrane and their expansion across the globe. For instance, in December 2017, AMNIOX Medical, Inc., (a TissueTech, Inc. company), had awarded a group purchasing agreement for Regenerative Skin Grafting Products with Premier. This agreement would allow the premier members, to take advantage of special terms pre-negotiated by Premier for the full AMNIOX Medical portfolio, of the wound and surgical solutions, which are known under the respective NEOX and CLARIX brand names.

·  In March 2017, Altacor had entered into the collaboration with NuVision Biotherapies to distribute the sight-saving therapy, Omnigen, in England, Scotland, and Wales. In October 2017, Bio-Tissue had entered into the strategic agreement with Bright Optical for bringing the PROKERA to the Canadian eyecare professionals market. In July 2016, Derma Sciences, Inc. had acquired BioD, LLC for an immediate transaction value of $21.3 million and a potential total transaction value of an estimated $77.8 million. BioD would operate as a wholly-owned subsidiary of Derma Sciences.  

· The market players are also investing to increase its production capabilities and market expansion around the globe. For instance, in June 2019, TissueTech, Inc., had closed an $82.25m in Series C equity financing. This funding would be used for regulatory approvals from the FDA for several of its development projects to comply with the agency’s new guidance documents and support ongoing commercial development.

Report Scope

·  The report covers the factors impacting the market, Porter 5 Forces, Competitive Scenario, Product Benchmarking, and company profiles.

Visualize the     composition of the global Ophthalmology Amniotic Membrane market products     across each indication, in terms of product type and End User highlighting     the critical commercial assets and players.

Identify commercial opportunities     in the global Ophthalmology Amniotic Membrane market by analyzing trends     and co-development deals.

View full report: https://www.datamintelligence.com/research-report/ophthalmology-amniotic-membrane-market

 Enquiry before buying: https://www.datamintelligence.com/enquiry/ophthalmology-amniotic-membrane-market

 About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

 For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: info@datamintelligence.com

Tel: +1 877 441 4866

Website:

www.datamintelligence.com

[pavanghage]

Cell Freezing Media Market Future Scope by 2021-2027: Business Size and Global Opportunity by Top Players, End User, Demand and Consumption Scenario

"

Cell Freezing Media Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.

Sample Copy of This Report:https://axelreports.com/request-sample/60042

A 360 degree outline of the competitive scenario of the Global Cell Freezing Media Market is presented by Axel Reports Market Insights. It has a massive data allied to the recent product and technological developments in the markets.

It has a wide-ranging analysis of the impact of these advancements on the market’s future growth, wide-ranging analysis of these extensions on the market’s future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Reasons for buying this report:

It offers an analysis of changing competitive scenario.

For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.

It offers seven-year assessment of Global Cell Freezing Media

It helps in understanding the major key product segments.

Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.

It offers regional analysis of Global Cell Freezing Media Market along with business profiles of several stakeholders.

It offers massive data about trending factors that will influence the progress of the Global Cell Freezing Media

Get ToC for the overview of the premium report @ https://axelreports.com/industry-analysis/2021-2027-global-and-regional-cell-freez/60042

By Market Players: ThermoFisher General Data Healthcare Atlanta Biologicals Cell Applications Akron Biotechnology Sigma-Aldrich MP Biomedicals Promocell Quality Biological Bulldog Bio GE Healthcare Life Sciences Hemacare Corporation FUJIFILM Wako Chemicals By Type Contains FBS Media No FBS Media By Application Scientific Research Industrial Production Other

A detailed outline of the Global Cell Freezing Media Market includes a comprehensive analysis of different verticals of businesses. North America, Latin America, Asia-Pacific, Africa, and Europe have been considered for the studies on the basis of several terminologies.

This is anticipated to drive the Global Cell Freezing Media Market over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Cell Freezing Media Market are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Cell Freezing Media Market. The feasibility of the new report is also measured in this research report.

Make an Enquiry for purchasing this Report :https://axelreports.com/enquiry-before-buying/60042

Table of Contents:

Global Cell Freezing Media Market Overview

Economic Impact on Industry

Market Competition by Manufacturers

Production, Revenue (Value) by Region

Production, Revenue (Value), Price Trend by Type

Market Analysis by Application

Cost Analysis

Industrial Chain, Sourcing Strategy and Downstream Buyers

Marketing Strategy Analysis, Distributors/Traders

Market Effect Factors Analysis

Global Cell Freezing Media Market Forecast

ABOUT US:

Axel Reports has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the world’s most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact: Axel Reports Akansha G (Knowledge Partner) Office No- B 201 Pune, Maharashtra 411060 Phone: US +18488639402 Email: sales@axelreports.com/ Web: https://axelreports.com/

"

[chetanagblog]

Cell Freezing Media Market is expected to reach USD 983.41 Mn. at a CAGR of 4.3% during the forecast period 2030.

[rishabh3210blog]

Global Cryoablation Market Size, Growth Analysis Report, Forecast to 2021-2027

The global cryoablation market is anticipated to grow at a considerable CAGR of 11.2% during the forecast period (2021-2027). The rising incidence of cancer and cardiovascular diseases and the rising demand for safer therapeutic options are some of the major factors that are contributing to the growth of the global cryoablation market. Cryoablation therapy is developing as an alternative for the treatment of various chronic diseases and cancer such as prostate cancer, lung cancer, and renal tumor.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/cryoablation-market

The change in lifestyles such as the boost in tobacco and alcohol consumption is leading to an increase in the prevalence of cancer diseases, which are driving the adoption of cryoablation therapy in various hospitals and clinics. Cryotherapy is also called a local treatment; the Cryotherapy is only treating the area where the patient has treatment. It doesn’t treat any cancer cells in other parts of the body.  

A Full Report of Global Cryoablation Market is Available at: https://www.omrglobal.com/industry-reports/cryoablation-market

Cryotherapy uses extremely cold gases (N2O or CO2) to destroy cancer cells. It's also called cryosurgery or cryoablation. During cryotherapy treatment, the doctor freezes the cancer cells to abstain from growing further with the help of cold gases. However, the lack of skilled medical physicians and a high cost of treatment are the major challenges for the market growth.

Global Cryoablation Market Report Segment

By Application

Oncology

Cardiology

Others

By End-user

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Global Cryoablation Market Report Segment by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of the Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cryoablation-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

[maximizegn1]

Cell Freezing Media Market size was valued at US$ 5.13 Bn. in 2020, Software Component is the dominating segment in the Cell Freezing Media Market.

[cool-cillian-murphy]

Trehalose Market Outlook: Big Expectations to Watch For

Brief Summary of Trehalose: Trehalose is a sugar, a naturally occurring disaccharide composed of two glucose molecules joined by an alpha-alpha glycosidic bond. It occurs naturally in lesser amounts in mushrooms, honey, shrimps, lobsters, certain seaweeds (algae), wine, beer, bread and alternative foods made by using baker’s or brewer’s yeast. Furthermore, as a food additive, trehalose is artificially created from corn starch with the help of many bacterial enzymes like alpha-amylase which is obtained from Bacillus licheniformis, and isoamylase from Pseudomonas amyloderamosa. Also it is heat stable and preserves the cell structure of foods after heating and freezing, so it is used as a food texturizer and stabilizer in dried foods, frozen foods, nutrition bars, fruit fillings and jams, instant noodles and rice, sugar coating, white chocolate, bakery cream, processed seafood and fruit juices.

Free Sample Report + All Related Graphs & Charts @ : https://www.advancemarketanalytics.com/sample-report/6048-global-trehalose-market-1

Latest Research Study on Global Trehalose Market published by AMA, offers a detailed overview of the factors influencing the global business scope. Trehalose Market research report shows the latest market insights with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Trehalose. This Report also covers the emerging player’s data, including: competitive situation, sales, revenue and global market share of top manufacturers are Cargill Inc. (United States),Hayashibara Co., Ltd. (Japan),Life Sciences Advanced Technologies (United States),The Ingredient House (United States),Penta Manufacturer (United States),Nagase America Corporation (United States),Meihua Group (China),Mitushi Biopharma (India),Lianmeng Chemical (China),Sinozyme Biotechnology (China),.

Trehalose Market Report offers a detailed overview of this market and discusses the dominant factors affecting the growth of the market. The impact of Porter's five armies on the market over the next few years has been discussed for a long time in this study. We will also forecast global market size and market outlook over the next few years. Types of Products, Applications and Trehalose Market Report Geographical Scope taken as the Main Parameter for Market Analysis. This Research Report Conducts an assessment of the industry chain supporting this market. It also provides accurate information on various aspects of this market, such as production capacity, available production capacity utilization, industrial policies affecting the manufacturing chain and market growth. The Global Trehalose Market segments and Market Data Break Down are illuminated below: by Type (Food Grade, Pharmaceutical Grade), Application (Food and Beverage, Pharmaceuticals, Cosmetics) What's Trending in Market: The inclination Towards Low-Calorie Sweetener and Low-Calorie Beverages

Challenges: Changing Consumer Preferences

Restraints: Nutrient Limitation a Common Cause of Trehalose Accumulation in Yeast

Market Growth Drivers: Increasing Demand for Trehalose from Food and Beverage Industry

Ability to Sustain and Preserve Wide Array of Biological Molecules

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc. Enquire for customization in Report @: https://www.advancemarketanalytics.com/enquiry-before-buy/6048-global-trehalose-market-1 Strategic Points Covered in Table of Content of Global Trehalose Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Trehalose market

Chapter 2: Exclusive Summary – the basic information of the Trehalose Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Trehalose

Chapter 4: Presenting the Trehalose Market Factor Analysis, Post COVID Impact Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020

Chapter 6: Evaluating the leading manufacturers of the Trehalose market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2026)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Finally, Trehalose Market is a valuable source of guidance for individuals and companies in their decision framework. Data Sources & Methodology The primary sources involves the industry experts from the Global Trehalose Market including the management organizations, processing organizations, analytics service providers of the industry’s value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects. In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age. Get More Information: https://www.advancemarketanalytics.com/reports/6048-global-trehalose-market-1 What benefits does AMA research studies provides?

·        Supporting company financial and cash flow planning

·        Latest industry influencing trends and development scenario

·        Open up New Markets

·        To Seize powerful market opportunities

·        Key decision in planning and to further expand market share

·        Identify Key Business Segments, Market proposition & Gap Analysis

·        Assisting in allocating marketing investments

Definitively, this report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. About Author:

Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies' revenues.

Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As. Contact Us:

Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 (206) 317 1218 sales@advancemarketanalytics.com   Connect with us at https://www.linkedin.com/company/advance-market-analytics https://www.facebook.com/AMA-Research-Media-LLP-344722399585916 https://twitter.com/amareport

[mrunalnerkarblog]

Cell Cryopreservation Market Emerging Trends and Will Generate New Growth

Cryopreservation is a process of maintaining biological samples in a form of suspended state at cryogenic temperature for considerable period and is used to preserve the fine structure of cells. Through this process, samples of cells, tissues, and organelles are cooled at very low temperatures (less than -2130 degree F), for preservation. Cryopreservation is primarily used in the preservation of oocytes and embryos with in-vitro fertilization (IVF) cycle, prior to chemotherapy for women diagnosed with breast cancer, in order to preserve their reproductive capacity.

The global cell cryopreservation market size was valued at US$ 4,027.9 million in 2018, and is expected to exhibit a CAGR of 22.5% over the forecast period (2018–2026).

Request for Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1698

Increasing government initiatives for preservation of stem cells is expected to augment the market growth

Government organizations’ initiatives for preservation of stem cells is a factor boosting the market growth. For instance, NCBP is the first and largest cord bank in the world, which recorded a collection of over 60,000 cord blood units, till 2016. NCBP has provided cord blood units for transplantation to over 4,900 recipients, throughout the world. Moreover, in 2011, Canada’s Ministry of Health, initiated Canada’s first national, publicly funded umbilical cord blood bank, which aims to provide donations for the allogeneic hematopoietic stem cell transplant.

Increasing launch of novel cryopreservation systems and approval of cryopreserved cells by regulatory authorities is also expected to bolster the market growth. For instance, in 2015, AMS Biotechnology Limited launched its new Stem-Cellbanker, a GMP grade cell cryopreservation media. Stem-Cellbanker is a freezing solution that is used for preservation of stem cells, induced pluripotent stem (iPS) cells, and other cells.

However, the adoption and development of alternative methods is expected to hinder the market growth. For instance, in May 2019, researchers at the University of Japan developed a technique to cryopreserve animal cells without using cryoprotectant agent. The researchers plan to apply this technique to a wide range of cells, specially cells sensitive to cryopreservation procedure.

Increasing R&D expenditure by pharmaceutical and biotechnology companies in North America is expected to bolster the market growth

North America holds dominant position in the global cell cryopreservation market, owing to increasing expenditure on research and development activities by pharmaceutical and other companies. For instance, in 2013, Amgen Foundation launched an international program named Amgen Biotech Experience. The foundation also collaborated with non-profit organizations such as Education Development Center, Inc. (EDC) and provided grants amounting to US$ 30 Mn to local, regional, and international nonprofit organizations to provide technical assistance in biotechnology research.

Increasing focus of manufacturers on developing novel products for preserving various cells for research and use in medical settings is a major factor propelling the market growth. For instance, in 2018, Vanessa Research Inc., a startup company, launched a compact device aimed at batch cryopreservation, which allows freezing of multiple tissue samples, simultaneously.

Moreover, in January 2015, the precision medicine initiative proposed by the U.S. Government led to the creation of a new biobank that contains medical records and genetic information. The biobank is used for research of new disease-gene associations and for medical care. Therefore, increasing launch of biobanks is expected to lead to high demand for cell cryopreservation services, thereby aiding in the market growth in the region.

To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/1698

Key Players

Major players operating in the global cell cryopreservation market include, General Electric Company, Thermo Fisher Scientific Inc., Merck KGaA, AMS Biotechnology (Europe) Limited, Miltenyi Biotec GmbH, BioLifeSolutions Inc., HiMedia Laboratories Pvt. Ltd., PromoCell GmbH, Corning Incorporated, Cooper Companies, Inc., and Planer PLC.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Phone: US +12067016702 / UK +4402081334027

Email: sales@coherentmarketinsights.com

[digitalconvo]

Biopreservation Market Newer Segments of Application and Forecast Till 2025

Global Biopreservation Market: Snapshot

Biopreservation is a process for conserving the tissues, organs and cells along with maintaining their integrity and functionality at different temperatures for a prolonged period of time. The necessary products for biopreservation are cryo bags, tubes, refrigerators, liquid nitrogen tanks, and freezers. These biopreservation equipment have applications in stem cell, DNA, and plasma and tissue research which helps the market to grow steadily. Various researches being carried out in cell therapy and the increasing number of bio banks also encourage market expansion. Currently, the  geriatric population is affected with many disorders related to their lifestyle, namely cardiovascular disease, chronic illness, hypertension, and cancer. Biopreservation applications such as drug discovery, regenerative medicines, and bio banking help the consumers or patients during their life span and even at the time of death.

The enormous growth in the global biopreservation market is accelerated by the rising healthcare expenditure, increasing trend of conserving cord blood stem cells of newborns, and the growing investments in research and development pertaining to this field. A considerable healthcare spending is expected to drive the gene banks, bio banks and hospitals to focus on biopreservation. High costs of advanced techniques and stability issues such as tissue injury during thawing and freezing have been considered as some of the primary factors  restraining the biopreservation market growth. One of the prominent names in the industry, BioLife Solutions has signed a ten years business supply agreement with Bellicum Pharmaceuticals for manufacturing, marketing of proprietary tissue and cell, and various cellular immunotherapies which target solid tumors and blood cancers. The influential regions for the biopreservation market are North America, Europe and Asia Pacific. Asia Pacific is expected to offer significant growth opportunities to market players, mostly driven by the demand arising from India and China.

Get Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1340

Global Biopreservation Market: Overview

Biopreservation involves maintaining the functionality and integrity of cells, tissues, and organs outside their natural environment for an extended period of storage at different temperatures. For instance, vaccines save 3 million lives every year in the U.S, however, vaccines worth US$ 20 million are wasted each year due to inadequate storage and improper refrigeration.

Biopreservation safeguards the stability, purity, and quality of biospecimens saved in hospitals, biobanks, and gene banks. For instance, preservation of red blood cells (RBCs) is required for the ready availability of safe blood for blood transfusion needs. The biopreservation of RBCs for clinical purposes can be divided on the basis of techniques used to attain biologic stability and safeguard a viable state after extended storage times.

Global Biopreservation Market: Key Trends

The major factors driving the global biopreservation market include increasing R&D expenditure, increasing number of sperm and egg banks, increasing demand for preserving the stem cells of newborns, and rising adoption of regenerative medicine.

Across the world, the increasing healthcare expenditure for health and well-being will stimulate the growth of the biopreservation market. This is because healthcare expenditure accounts for a significant part of the developmental budget of most countries. According to data from the World Bank, public healthcare spending is expected to rise at a substantially high rate, which along with a substantial healthcare spending will be an important driver for gene banks, hospitals, and biobanks, which are the key end-users of biopreservation market.

A large population afflicted with chronic disorders such as cardiovascular diseases, diabetes, cancer, and hypertension as well as lifestyle diseases will bolster the market’s growth. The increasing public and private spending on, medical goods and services, rising disposable income, increasing demand for biobanking services for the preservation of cells, tissues, and organs, and rising disposable income are also expected to further enhance the growth of the global biopreservation market.

Global Biopreservation Market: Market Potential

In a recent development in the biopreservation industry, BioLife Solutions, a leading name in developing, manufacturing, and marketing of proprietary cell and tissue has entered into a ten year business supply agreement with Bellicum Pharmaceuticals. The latter is a leading name in the development of cellular immunotherapies for cancers and inherited blood disorders. On account of this supply agreement, BioLife’s CryoStor cell freeze media is incorporated into Bellicum’s production process for various cellular immunotherapies that targets blood cancers and solid tumors.

In another industry development, BioLife Solutions has entered into a partnership with transportation firm MNX and expects heightened demand for its biologistics services with the entry of more cell therapies into the clinic.

To get Incredible Discounts on this Report, Click Here @https://www.tmrresearch.com/sample/sample?flag=D&rep_id=1340

Global Biopreservation Market: Regional Outlook

The global biopreservation market can be analyzed with respect to the regional segments of North America, Europe, Asia Pacific, and Rest of the World. In North America, the U.S. accounts for almost half the revenue of the region. This is due to the increasing demand for detection of chronic diseases, government stipulations for the ethical usage of biological samples, and introduction of newer of biopreservation methodologies.

Asia Pacific biopreservation market, driven by India and China will display a sustainable growth over the next couple of years

Global Biopreservation Market: Competitive Analysis

Some of the key companies operating in the global Biopreservation market include Thermo Fischer Scientific Inc., VWR Corporation, Lifeline Scientific Inc., BioCision LLC, Custom Biogenic Systems Inc., Princeton Cryotech Inc., Sigma-Aldrich Corporation, Biolife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., and So-Low Environmental Equipment Co. Inc.

Top companies in the market are focused on mergers and acquisitions, practicing effective services, and develop new products to stay competitive in the biopreservation market. Expanding geographical reach and developing a broad product portfolio with respect to refrigerators, freezers, and consumables is also leading to the increased market share of some of the top players.

Request For TOC @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1340

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:    

TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States

Tel: +1-415-520-1050